Pyxis Oncology grabs $152m Series B

Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this